BIO International Convention

Join us to explore ‘LIMITLESS’ possibilities and seize today's unprecedented momentum to realize a biotech-driven future where we can cure disease, and create a healthier world through science.

BIO's exciting programming covers the industry's most relevant and timely topics, providing valuable insights from the top leaders in biotech. 

View 40+ start-ups pitch their innovations to investor judges for feedback; featuring CLS WIB-FAST women founders and SPARK at Stanford academic technology transfer entrepreneurs

"We're thrilled to be returning to the most important event of the year: BIO 2022," says Charles Camp, Director & Financial Controller at Scendea. "The possibilities to collaborate are limitless."

Our system makes it easy to search for and identify potential partners and request meetings with prospective biotech investors and senior business development executives. 

Join us to explore ‘LIMITLESS’ possibilities and seize today's unprecedented momentum to realize a biotech-driven future where we can cure disease, and create a healthier world through science.

Build your network, stay on top of industry topics, advocate for issues critical to your interests, gain access to policymakers, and save money.

"I'm really excited for BIO 2022 – for all of us to come together for the first time in three years in person," says John Crowley, CEO of Amicus Therapeutics.

"I'm looking forward to seeing and speaking with all of you face-to-face on the convention floor and all the networking events," says Tom Defay, Deputy Head Diagnostics Strategy & Development, Alexion, AstraZeneca Rare Disease. .

"I'm excited to be back at BIO and meet some leading industry and scientific leaders and find ways to collaborate," says Amit Mehta, VP at Genentech Research & Early Development. 

"Ahead of us are limitless possibilities to meet people, explore new ideas, listen to what people have been doing for the last two years from all over the world," says Jeremy Levin, Chairman & CEO, Ovid Therapeutics. 

"The in-person connections we make are very important and help us do our jobs advocating for patients," says Deborah Darcy, Senior Director, Government Relations, American Kidney Fund.

"BIO 2022 gives me an opportunity to work with people from around the world with whom we collaborate to deliver products to patients," says Joseph Panetta, President and CEO, Biocom California.

BIO is excited to welcome international delegations from around the world to the BIO International Convention in June in San Diego, California.

"We are waiting for a hundred participants from the most innovative French biotech companies gathered under the banner of the French healthcare brand," says Anahid Ilias of Business France.

"Now that we can all be together in person for BIO 2022, we are limitless and will be even stronger," says Paul Hastings, President & CEO, Nkarta, and Chairperson, Board of Directors, BIO.

"To be face-to-face increases the chance to making unexpected partnerships again," says Norberto Prestes, Director, Brazilian Pharmochemicals Manufacturers Association.

"BIO is the premier meeting for international partnering, networking and high quality education for the biotechnology and pharmaceutical industries," says Patricia Sinatra, Head of Business Development, Stadius Biopharma.

"Coming to BIO gives us the chance to share what we have to offer and connect with others who are aligned with our mission," says Hollie Schmidt, VP at Accelerated Cure Project for Multiple Sclerosis.

"I'm especially looking forward to talking about the opportunities in front of us to advance women's health, an area of both significant unmet need and incredible opportunities ahead," says Kevin Ali, CEO, Organon.

"I'm here to encourage you to join our Super Session for a very dynamic discussion on lessons learned during the COVID-19 Pandemic," says Stanley C. Erck, President and CEO, Novavax.